Completed
Belimumab in Remission of VASculitis
NCT01663623
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +17 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Covina, California, United States